Summary High body weight is associated with increased production of oestrogens which may influence the clinical behaviour of breast cancer. We have examined the influence of body weight on the response to endocrine therapy, steroid hormone receptor content and survival in 227 women who either presented with or developed advanced cancer of the breast. One hundred and thirty-three (59%) patients presented with operable disease and 94 (41%) with locally advanced tumours. Two hundred (88%) were treated by tamoxifen and 27 (12%) by ovarian ablation.High body weight was correlated with advanced tumour stage (P=0.002) and progesterone receptor (PR) positivity (P=0.01), but not with the presence of oestrogen receptor (ER P=0.21). The association between high body weight and PR positivity was particularly noticeable among ER positive tumours. There was no significant relationship between the nature of the response to therapy and weight (P=0.57). There was no significant difference in survival from the start of endocrine therapy (P=0.95), nor the time to progression of disease (P=0.29) between patients above and below the median weight of 64kg. Among the patients with operable disease, there was no difference in overall survival (P=0.42), relapse free survival (P=0.69), and survival from the start of endocrine therapy (P=0.85) according to body weight.Most epidemiological evidence suggests that high body weight and obesity are correlated with the incidence of breast cancer, particularly in postmenopausal women (Dewaard, 1982). Furthermore, these factors are generally associated with a worse prognosis (Papatestas et al., 1986;Abe et al., 1976;Eberlein et al., 1985;Greenberg et al., 1985;Tartter et al., 1981;Newman et al., 1986;Boyd et al., 1981), although one small study did not confirm this effect (Sohrabi et al., 1980). Similarly in mice, obesity and a fat enriched diet increase the incidence and speed of onset of mammary tumours (Waxler et al., 1979).In postmenopausal women the major source of oestrogens is the conversion of androstenedione, derived from the adrenal gland, to oestrone in body fat by the aromatase system (Cloncope, 1971;MacDonald et al., 1969). The strong correlation between the production of oestrone, the degree of this conversion and indices of obesity (e.g., weight, percentage of ideal weight and weight:height ratio) suggests that the excess production of steroid hormones within body fat which promotes the growth of mammary epithelial cells, may be the mechanism whereby there is an association between body weight and tumour incidence (Rizkallah et al., 1975; McDonald et al., 1978; Kirschner et al., 1982). This is supported by the report of lower levels of sex hormone binding globulin in the obese which may lead to higher levels of free oestrogens (Kirschner et al., 1982).Our working hypothesis for this study was that the greater endogenous production of growth promoting steroids in women of above average weight might override the effects of endocrine treatment and lead to a lower response rate and red...